EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Chalcone‐based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies

Hwa Young Lee, Ahmed Elkamhawy, Ahmed A Al-Karmalawy, Hossam Nada, Simone Giovannuzzi, Claudiu T Supuran, Kyeong Lee

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Hwa Young Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: BK21 FOUR Team and Integrated Research, Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Sulfonamides, Carbonic Anhydrase II, Benzenesulfonamides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education of Korea through NRF, Korean government (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sulfonamides are promising classical carbonic anhydrase (CA; EC 4.2.1.1) inhibitors, being used for several medical purposes such as diuretics, anticonvulsants, topically acting antiglaucoma agents, for antiobesity and anticancer therapies. Herein, a series of chalcone‐based benzenesulfonamides ( 3a‒m ) was synthesized and assessed for its inhibitory activity against a panel of four human carbonic anhydrases (hCA isoforms I, II, IX, and XII). Most compounds displayed single‐ to double‐digit nanomolar inhibition constants ( K i s), with some derivatives being more potent and/or selective than the standard drug acetazolamide (AAZ). Among the synthesized compounds, 3g compound demonstrated the highest inhibitory activity against the hCA II isoform ( K i = 2.5 nM) with 30‐, 9‐, and 11‐fold selectivity for hCA II over the I, IX, and XII isoforms, respectively. Structure–activity relationships for different substitution patterns were analyzed. Additionally, a molecular docking study showed that compound 3g bound to hCA II by coordinating with the zinc ion through the deprotonated benzenesulfonamide moiety, in addition to a hydrogen bond formed between an oxygen of the sulfonamide moiety and Thr199. Moreover, the chalcone core participated in van der Waals interactions with some active site residues, such as Ile91, Val121, and Leu198. Consequently, this report introduces a successful approach toward identifying compound 3g as a highly potent and selective chalcone‐based benzenesulfonamide inhibitor of hCA II worthy of further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsSulfonamidesCarbonic Anhydrase IIBenzenesulfonamidesDrug DesignMolecular Docking SimulationHumansStructure-Activity RelationshipMolecular StructureChalconesDose-Response Relationship, DrugChalconeComputer Simulation

Stichwörter der Autor:innen

aldol condensationcarbonic anhydrase inhibitorschalcone‐based benzenesulfonamidesmolecular dockingsynthesis

Substanzen

Carbonic Anhydrase InhibitorsSulfonamidesCarbonic Anhydrase IIBenzenesulfonamidesChalconesChalcone

Autor:innen und Institutionen

  • BK21 FOUR Team and Integrated Research, Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea.
  • Department of Chemistry, School of Sciences and Humanities, Nazarbayev University, Astana, Kazakhstan.
  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, 6th of October City, Giza, Egypt.
  • Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, Italy.

Förderung

  • Ministry of Education of Korea through NRF
  • Korean government (MSIT)

Zitieren

APA

Lee, H. Y., Elkamhawy, A., Al-Karmalawy, A. A., Nada, H., Giovannuzzi, S., Supuran, C. T., & Lee, K. (2024). Chalcone‐based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400069

Vancouver

Lee HY, Elkamhawy A, Al-Karmalawy AA, Nada H, Giovannuzzi S, Supuran CT, et al. Chalcone‐based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400069

BibTeX
@article{Lee2024,
  author = {Lee, Hwa Young and Elkamhawy, Ahmed and Al-Karmalawy, Ahmed A and Nada, Hossam and Giovannuzzi, Simone and Supuran, Claudiu T and Lee, Kyeong},
  title = {Chalcone‐based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400069}
}
Kostenlos starten →